Bruno has been a Managing Director with Ardian since 2002. He was previously a Director at PAI Partners. He has extensive investment experience in the food, chemicals, industrials and healthcare sectors. Bruno has worked in the pharmaceutical industry with Rhone-Poulenc, in management consulting with Corporate Decisions and in investment banking with Triago. He qualified as a Medical Doctor and received an MBA from The Wharton School. Currently sits on the board of Envision Pharma Group, Inula, DRT and Solina.
Back to all profiles